Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias W Beckmann

Showing results (651-660 of 799) with videos related to

Pageof 80
Sort By:
International Journal of Cancer|August 28, 2020
Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancerPik-Fang Kho, Frederic Amant, Daniela Annibali, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2016
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer SurvivalLara E Sucheston-Campbell, Rikki Cannioto, Alyssa I Clay, et al.
British Journal of Cancer|November 3, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium StudyAshley Weir, Eun-Young Kang, Nicola S Meagher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 18, 2014
Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancerMatthew S Block, Bridget Charbonneau, Robert A Vierkant, et al.
European Journal of Human Genetics : EJHG|January 27, 2023
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European womenGisella Figlioli, Amandine Billaud, Thomas U Ahearn, et al.
Journal of the National Cancer Institute|July 2, 2009
Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042Roger L Milne, Javier Benítez, Heli Nevanlinna, et al.
Breast Cancer Research : BCR|April 8, 2015
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapyJieping Lei, Anja Rudolph, Kirsten B Moysich, et al.
Scientific Reports|December 2, 2015
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1Timothy H T Cheng, Deborah Thompson, Jodie Painter, et al.
Plos One|May 6, 2016
RAD51B in Familial Breast CancerLiisa M Pelttari, Sofia Khan, Mikko Vuorela, et al.
Breast Cancer Research : BCR|February 18, 2016
Genetic predisposition to ductal carcinoma in situ of the breastChristos Petridis, Mark N Brook, Vandna Shah, et al.
Pageof 80

Showing results (651-660 of 799) with videos related to

Sort By:
Pageof 80
International Journal of Cancer|August 28, 2020
Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancerPik-Fang Kho, Frederic Amant, Daniela Annibali, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2016
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer SurvivalLara E Sucheston-Campbell, Rikki Cannioto, Alyssa I Clay, et al.
British Journal of Cancer|November 3, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium StudyAshley Weir, Eun-Young Kang, Nicola S Meagher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 18, 2014
Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancerMatthew S Block, Bridget Charbonneau, Robert A Vierkant, et al.
European Journal of Human Genetics : EJHG|January 27, 2023
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European womenGisella Figlioli, Amandine Billaud, Thomas U Ahearn, et al.
Journal of the National Cancer Institute|July 2, 2009
Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042Roger L Milne, Javier Benítez, Heli Nevanlinna, et al.
Breast Cancer Research : BCR|April 8, 2015
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapyJieping Lei, Anja Rudolph, Kirsten B Moysich, et al.
Scientific Reports|December 2, 2015
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1Timothy H T Cheng, Deborah Thompson, Jodie Painter, et al.
Plos One|May 6, 2016
RAD51B in Familial Breast CancerLiisa M Pelttari, Sofia Khan, Mikko Vuorela, et al.
Breast Cancer Research : BCR|February 18, 2016
Genetic predisposition to ductal carcinoma in situ of the breastChristos Petridis, Mark N Brook, Vandna Shah, et al.
Pageof 80